Reviva Pharmaceuticals (RVPH) Earnings Date, Estimates & Call Transcripts $1.23 -0.01 (-0.81%) (As of 01:30 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Reviva Pharmaceuticals Latest Earnings SummaryLatest Earnings DateAug. 14EstimatedActual EPS (Aug. 14) -$0.26 Beat By $0.02 Consensus EPS (Aug. 14) -$0.28 Reviva Pharmaceuticals announced Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.26, which topped analysts' consensus estimates of -$0.28 by $0.02. With a trailing EPS of -$1.11, Reviva Pharmaceuticals' earnings are expected to grow next year, from ($0.98) to ($0.81) per share. Get Reviva Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Reviva Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRVPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RVPH Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Reviva Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.28-$0.28-$0.28Q2 20241-$0.28-$0.28-$0.28Q3 20241-$0.25-$0.25-$0.25Q4 20241-$0.26-$0.26-$0.26FY 20244-$1.07-$1.07-$1.07Q1 20251-$0.26-$0.26-$0.26Q2 20251-$0.27-$0.27-$0.27Q3 20251-$0.22-$0.22-$0.22Q4 20251-$0.18-$0.18-$0.18FY 20254($0.93)($0.93)($0.93) Reviva Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/14/2024--$0.28-$0.26+$0.02-$0.26--5/14/2024Q1 2024-$0.28-$0.25+$0.03-$0.25--4/15/2024Q4 2023--$0.35 -$0.35-$0.35--11/14/2023Q3 2023-$0.35-$0.44 -$0.09-$0.44--8/14/2023Q2 2023-$0.29-$0.55 -$0.26-$0.55--5/15/2023Q1 2023-$0.36-$0.30+$0.06-$0.30-- Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022-$0.23-$0.38 -$0.15-$0.38-- Reviva Pharmaceuticals Earnings - Frequently Asked Questions When did Reviva Pharmaceuticals announce their last quarterly earnings? Reviva Pharmaceuticals (NASDAQ:RVPH) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on RVPH's earnings history. Did Reviva Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Reviva Pharmaceuticals (NASDAQ:RVPH) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.28) by $0.02. Learn more on analysts' earnings estimate vs. RVPH's actual earnings. How much profit does Reviva Pharmaceuticals generate each year? Reviva Pharmaceuticals (NASDAQ:RVPH) has a recorded net income of -$39.26 million. RVPH has generated -$1.11 earnings per share over the last four quarters. What is Reviva Pharmaceuticals's EPS forecast for next year? Reviva Pharmaceuticals's earnings are expected to grow from ($0.98) per share to ($0.81) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies LFVN Earnings OGI Earnings TSVT Earnings ADAP Earnings ELDN Earnings HRTX Earnings TIL Earnings FULC Earnings CKPT Earnings GOSS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] This page (NASDAQ:RVPH) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
